Blumhouse Atomic: Jason Blum and James Wan have officially introduced a new name for their combined horror production company, unveiling Blumhouse Atomic nearly two years after the merger of Blumhouse and Atomic Monster. The rebranding marks a significant milestone for two of Hollywood’s most influential horror producers, whose combined productions have reportedly generated more than $2.5 billion in worldwide box office revenue against production budgets totaling less than $330 million.
Announced on November 3, 2026, the new corporate identity replaces the previous name, Blumhouse Atomic Monster. However, the change does not mean that the two original studios are disappearing. Blumhouse and Atomic Monster will continue to operate as separate production labels, with their respective creative teams developing movies and television projects.
The announcement arrives during a particularly successful period for the combined company, with several recent horror releases delivering impressive theatrical results. The new name also signals an ambition to expand the company’s entertainment properties beyond traditional movie theaters into television, gaming, live experiences, and other platforms.
Jason Blum and James Wan Reveal Blumhouse Atomic
The Blumhouse Atomic rebranding represents the next phase of the partnership between Jason Blum and James Wan.
Blumhouse, founded by Jason Blum, established itself as a major force in low-budget horror filmmaking through successful projects such as Paranormal Activity, Get Out, The Purge, and Five Nights at Freddy’s.
Atomic Monster, founded by James Wan, became internationally recognized for creating and developing major horror franchises, including The Conjuring, Insidious, and Saw. Wan also directed commercially successful films such as Aquaman and M3GAN.
The companies combined their operations in 2024, bringing two influential horror production businesses under a shared corporate structure.
According to Jason Blum, the partnership has delivered the results the founders hoped to achieve. He described Blumhouse Atomic as a natural evolution of the merged companies, emphasizing that the business combines the scale of a major studio with the creative independence and financial discipline of an independent production company.
James Wan also highlighted the importance of discovering new filmmakers and supporting distinctive storytelling. He explained that his own career began with opportunities to make smaller films, and he wants the new company to provide similar opportunities for emerging horror directors.
$2.5 Billion Box Office Against Production Budgets Below $330 Million
One of the most significant aspects of the Blumhouse Atomic announcement is its financial performance.
Since the 2024 merger, the combined horror slate has reportedly earned more than $2.5 billion worldwide against production budgets totaling less than $330 million.
The company also generated more than $1 billion in worldwide box office revenue in each of 2025 and 2026. Its 2026 releases alone reportedly earned nearly $1.3 billion globally on production budgets below $70 million.
These figures demonstrate the commercial appeal of horror movies when creative concepts, audience interest, and controlled production costs align.
It is important to note that worldwide box office revenue is not the same as studio profit. The reported production budgets do not necessarily include marketing, distribution expenses, theater revenue shares, or other costs. Nevertheless, the figures illustrate the scale of the company’s theatrical performance.
For Blumhouse Atomic, the business model centers on producing distinctive genre films without relying exclusively on enormous production budgets.
Also read: The Highest-Paid TV Actors Per Episode, From Seinfeld to The Morning Show
Obsession and Backrooms Become Major Horror Successes
Two of the company’s recent breakout titles are Obsession, directed by Curry Barker, and Backrooms, directed by Kane Parsons.
Obsession reportedly generated approximately $520 million worldwide, making it one of the most notable horror successes of 2026. The film’s performance demonstrated the potential of original horror stories to attract audiences without depending entirely on established franchises.
Backrooms also became a major theatrical success, reportedly earning more than $400 million worldwide. Directed by Kane Parsons, the film draws on the internet-born horror phenomenon associated with unsettling, seemingly endless liminal spaces.
The success of both films has strengthened the company’s strategy of investing in new creative voices.
The two projects also represent an important development for the horror genre. Rather than focusing exclusively on familiar properties, Blumhouse Atomic is demonstrating that original concepts can become major commercial attractions.
Blumhouse and Atomic Monster Will Remain Separate Labels
Although Blumhouse Atomic is now the shared corporate name, the original production brands will continue to operate independently.
Blumhouse will maintain its creative identity, while Atomic Monster will continue developing its own projects under James Wan’s leadership.
This structure is intended to preserve the individual strengths of both companies while allowing them to benefit from shared resources, business opportunities, and franchise development.
The arrangement also gives the company flexibility to work across different genres and production scales.
Blumhouse Atomic is expanding its approach to filmmaking by focusing on cost-efficient productions, established franchises, and emerging filmmakers. Sam Zimmerman, appointed senior vice president of development and acquisitions, is expected to oversee a slate that includes genre projects with budgets under $5 million.
The company has also established a first-look deal with horror production company Divide/Conquer to develop high-concept genre films.
James Wan’s Saw Franchise Returns to the Partnership
Another important development involves the Saw franchise.
James Wan co-created Saw with Leigh Whannell, and the franchise became one of the most influential horror properties of the 2000s.
Blumhouse acquired rights related to future Saw projects in 2025, bringing the franchise back into the company’s broader horror portfolio. Lionsgate retains its existing ownership and distribution rights, while other parties continue to hold interests in the existing film library.
Jason Blum described the return of Saw to James Wan as an example of the opportunities created by the partnership.
New chapters of Saw are being developed, alongside plans for additional installments of Paranormal Activity and Blair Witch.
The move highlights the company’s strategy of combining recognizable horror franchises with original projects.
Blumhouse Atomic’s Upcoming Movies and 2027 Slate
The new company is preparing a range of projects for its upcoming slate, combining established horror properties with original stories.
The announced titles include:
- River
- The Revenge of La Llorona
- The Exorcist: Martyrs
- Anything But Ghosts
- Paranormal Activity
- Molepeople
- Blair Witch
- Sleepover
- Seasons
The slate reflects the company’s continued commitment to horror and suspense while allowing space for filmmakers to experiment with new ideas.
Mike Flanagan’s involvement in the new Exorcist project is also among the developments attracting attention from horror fans.
Beyond theatrical releases, Blumhouse Atomic is exploring television adaptations, gaming, and live entertainment. Its broader projects include Scarpetta for Prime Video, The Rainmaker for USA Network, the game Grave Seasons, and a Broadway adaptation of Paranormal Activity.
These initiatives could help the company expand the reach of its franchises while creating additional opportunities for its creative teams.
What Blumhouse Atomic’s New Name Means for Hollywood Horror
The introduction of Blumhouse Atomic represents more than a corporate rebranding. It reflects the changing landscape of Hollywood, where production companies increasingly seek to balance theatrical success, franchise development, and opportunities across multiple entertainment platforms.
Jason Blum’s experience in cost-conscious filmmaking and James Wan’s expertise in building globally recognized horror franchises give the company a distinctive position in the industry.
The reported $2.5 billion worldwide box office milestone against production budgets below $330 million underscores the commercial potential of its strategy, although profitability depends on additional expenses and revenue-sharing arrangements.
The company’s emphasis on original stories, emerging filmmakers, and established franchises could shape its next phase of growth.
For horror fans, the new identity also means that familiar names such as The Conjuring, Insidious, Saw, Paranormal Activity, and Blair Witch remain central to the company’s future.
As Blumhouse Atomic moves forward, the partnership between Jason Blum and James Wan is positioned to continue influencing the horror genre, both through major theatrical releases and new entertainment experiences.
Talent managers and agents: own the profile buyers check first.
Claim Verified Talent Badge — $299/yr
